HomeNRX • CVE
add
Nurexone Biologic Inc
Previous close
$0.85
Day range
$0.78 - $0.89
Year range
$0.53 - $1.14
Market cap
64.22M CAD
Avg Volume
93.90K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.82M | 38.03% |
Net income | -1.85M | -39.32% |
Net profit margin | — | — |
Earnings per share | -0.02 | — |
EBITDA | -1.78M | -36.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.23M | -48.51% |
Total assets | 2.86M | -13.00% |
Total liabilities | 1.33M | 85.77% |
Total equity | 1.53M | — |
Shares outstanding | 81.43M | — |
Price to book | 42.50 | — |
Return on assets | -182.05% | — |
Return on capital | -306.73% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.85M | -39.32% |
Cash from operations | -1.07M | -22.64% |
Cash from investing | -2.00K | 97.18% |
Cash from financing | 1.59M | 3,513.64% |
Net change in cash | 640.00K | 173.56% |
Free cash flow | -459.38K | 17.55% |
About
Founded
2011
Website
Employees
9
